To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·08-02
      ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 223,924 shares, the number of shares held decreased 2.06% compared to the previous period and now represents 1.01% of the total position.
      6.83K1
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-02
      ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 11,186 shares, the number of shares held decreased 2.06% compared to the previous period and now represents 1.82% of the total position.
      71Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-02
      ARKG Investment Tracker position change: Decreased position in Alamar Biosciences by 20,162 shares, the number of shares held decreased 2.06% compared to the previous period and now represents 1.54% of the total position.
      41Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-02
      ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 37,383 shares, the number of shares held decreased 2.06% compared to the previous period and now represents 2.75% of the total position.
      167Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-02
      ARKG Investment Tracker position change: Decreased position in Generate Biomedicines by 26,061 shares, the number of shares held decreased 2.06% compared to the previous period and now represents 1.11% of the total position.
      31Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-02
      ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 100,487 shares, the number of shares held decreased 2.06% compared to the previous period and now represents 2.5% of the total position.
      132Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-02
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 35,428 shares, the number of shares held decreased 2.06% compared to the previous period and now represents 2.54% of the total position.
      34Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-02
      ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 158,270 shares, the number of shares held decreased 2.06% compared to the previous period and now represents 1.46% of the total position.
      54Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-02
      ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 9,401 shares, the number of shares held decreased 2.06% compared to the previous period and now represents 1.98% of the total position.
      80Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-02
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 56,168 shares, the number of shares held decreased 2.06% compared to the previous period and now represents 1.9% of the total position.
      67Comment
      Report
       
       
       
       

      Most Discussed